Icd 10 insomnia back pain11/2/2023 This study highlights a concern when patients self-titrate cannabis for medical purposes without patient oversight and guidance. Shared Decision Making and Communication.Scientific Discovery and the Future of Medicine.Health Care Economics, Insurance, Payment.Clinical Implications of Basic Neuroscience.Challenges in Clinical Electrocardiography.CUD Symptoms by Intervention Group at Each Study Timepoint Severity of Treatment Emergent Adverse EventsĮFigure. Treatment Emergent Adverse EventsĮTable 14. Primary Outcomes in Participants With Blinded AssessmentsĮTable 13. Sensitivity Analysis of Primary Outcomes in MMC Participants With Metabolites, and in WLC Participants Without Detectable MetabolitesĮTable 12. Sensitivity Analysis of Primary Outcomes by Randomization Group With Adjustment Using Propensity ScoresĮTable 11. Sample Characteristics at Screening Those Randomized to MMC Who Obtained vs Did Not Obtain MMCĮTable 10. Exploratory Cannabis Use and Symptom Rating OutcomesĮTable 9. Cannabis Use Disorder Symptoms Endorsed in Each GroupĮTable 8. ![]() CUD Diagnosis by Group and Study TimepointĮTable 7. Secondary Outcomes (SF-12 Mental and Physical Well-Being, and Cognitive Outcomes) by Intervention GroupĮTable 6. Cannabinoid Metabolite Measurements at Week 12 by Intervention GroupĮTable 5. Self-Reported CBD:THC Ratio and Method of Use by Intervention GroupĮTable 4. Concomitant Medications at Enrollment by Intervention GroupĮTable 3. Medical and Psychiatric History of the Overall Study SampleĮTable 2.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |